美国放射肿瘤住院医师培训项目资源差异调查
该研究调查了2018-2019学年美国94个放射肿瘤住院医师培训项目的师资与设备资源,发现各项目在主治医师数量、专用外照射设备、质子治疗可及性及近距离治疗技术方面存在显著差异,常规技术则全部普及。
要点
- 94个项目中主治医师中位数13人(范围4-71),物理师和生物学家中位数分别为9人和3人。
- 伽玛刀、射波刀和MRI直线加速器分别仅49(52%)、21(22%)和7(8%)个项目拥有。
- 仅19个项目(20%)有院内质子治疗,37个项目(39%)通过附属机构轮转提供质子培训。
核心结论
- 2018-2019学年美国放射肿瘤住院医师培训项目间资源存在显著差异,该数据可作为未来干预的基线。
研究设计与样本
- 通过查询各住院医师项目网站和FREIDA数据库获取师资与治疗模式信息,数据截至2019年4月30日,共纳入94个项目。
主要发现
- 主治医师中位数13人(范围4-71),物理师和生物学家中位数分别为9人和3人。
- 3DCRT、IMRT、电子线、SBRT/SRS在所有项目中均可用。
- 伽玛刀、射波刀和MRI直线加速器分别在49(52%)、21(22%)和7(8%)个项目中可用。
- 仅19个项目(20%)有院内质子治疗,37个项目(39%)通过附属机构轮转提供质子培训。
- 前列腺、妇科和乳腺近距离治疗分别在81(86%)、82(87%)和58(62%)个项目中可用;81个项目(86%)有高剂量率近距离治疗,仅20个(21%)有低剂量率近距离治疗。
关键数值与推荐
- 主治医师中位数13人(范围4-71),物理师中位数9人,生物学家中位数3人。
- 伽玛刀可用率52%(49/94),射波刀22%(21/94),MRI直线加速器8%(7/94)。
- 院内质子治疗可用率20%(19/94),通过附属机构轮转提供质子培训39%(37/94)。
- 前列腺近距离治疗可用率86%(81/94),妇科87%(82/94),乳腺62%(58/94)。
- 高剂量率近距离治疗可用率86%(81/94),低剂量率21%(20/94)。
临床怎么用
- 申请住院医师培训时需关注各项目专用设备(如伽玛刀、射波刀、MRI直线加速器)和质子治疗可及性差异。
- 近距离治疗培训资源不均,尤其低剂量率近距离治疗仅约五分之一项目提供,需针对性补充轮转。
局限性
- 数据来源于项目网站和FREIDA数据库,可能未完全反映实际资源或存在更新滞后。
- 仅纳入2018-2019学年94个项目,未涉及培训质量或临床结局的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this research was to assess the existing variations in the residency training resources among radiation oncology (RO) residency programs in the United States. We queried each residency program website and Fellowship Residency Electronic Interactive Data Access System website (www.freida.ama-assn.org) to obtain information on faculty and available treatment modalities. The data were continuously updated, most recently as of April 30, 2019. A total of 94 RO residency programs were identified during the academic year 2018-2019, and data were collected. The median number of attending physicians was 13 (range, 4 -71). The median number of physicists and biologists were 9 and 3, respectively. The conventional techniques, including 3 dimensional conformal radation therapy, intensity modulated radiation therapy, electron therapy, and stereotactic body radiation therap/stereotactic radiosurgery, were available in all residency programs. In terms of specialized external beam radiation therapy machines, gamma knife, CyberKnife, and magnetic resonance imaging (MRI) linear accelerator were available in 49 (52%), 21(22%), and 7 (8%) programs, respectively. Only 19 programs (20%) had in-house proton therapy availability; however, 37 programs (39%) offered proton therapy training via resident rotation at an affiliated institution. Prostate, gynecologic, and breast brachytherapy were available in 81 (86%), 82 (87%), and 58 (62%) programs, respectively. Eighty-one (86%) programs reported to have high dose rate, and only 20 (21%) programs had low dose rate brachytherapy. Our study found that marked variations exist among RO residency programs in the United States during academic year 2018-2019 and will serve as a baseline for future intervention.
引用
- Vengaloor Thomas T, Perekattu Kuruvilla T, Kahn J, et al. Variations in Resources Among Radiation Oncology Residency Programs in the United States. Adv Radiat Oncol. 2020. PMID: 33521395. doi:10.1016/j.adro.2020.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。